#cdsco

4 stories

#india #ai breast cancer screening #alteplase #breast cancer diagnostics #c-met #central drugs standard control organisat #children under four #clinical trials #cough syrup #dcgi #defective medical devices #dghs

NFI Lists Unapproved Drugs, DCGI Demands Explanation
India's National Formulary includes drugs not approved by central drug regulator, prompting DCGI to seek IPC's rationale.
The Economic Times · 1m
Lord's Mark AI breast cancer screening nears clinical trials
Lord's Mark's AI-powered radiation-free breast cancer screening technology advances to final clinical trials across global markets.
The Economic Times · 1m
India's medical device rules to tighten safety enforcement
New rules could stop unsafe medical devices faster by letting regulators order destruction and halt sales
The Economic Times · 1m
India to add red warning labels to cough syrup bottles
New rules would ban use in children under four and require pictorial labels showing older kids.
The Economic Times · 1m